English
Español
Deutsch
Italia
Svenska
Nederlands
Dansk
Participate in a study
Investigators
Careers
Events
0
out of
results
Show More
Solutions
Worldwide Flex
Biostatistics & Programming
Clinical Analytics
Clinical Operations
Data Management
Functional Services
Medical Writing
Oversight Monitoring
Patient Safety
Bioanalytical Lab
Bioanalytical Lab Virtual Tour
Full Services Phase I-IV
Phase I & Clinical Pharmacology Services
Phase II-III Clinical Trials
Phase IIIB-Phase IV Clinical Trials
Transition Studies
Expertise
Oncology
Phase of Development
Early Phase Oncology
Late Phase Oncology
Cancer Indication
Bladder Cancer
Breast Cancer
Head & Neck Cancer
Hematologic Cancer
Lung Cancer
Melanoma & Skin Cancer
Ovarian Cancer
Pancreatic Cancer
Rare Cancer
Drug Modality
Antibody-Drug Conjugates
Immuno-Oncology
Oncology Cell & Gene Therapy
Neuroscience
Alzheimer’s Disease & Dementia
Neurology
Pain
Psychedelics
Psychiatry
Internal Medicine
Autoimmune
Cardiovascular
Endocrine and Metabolic Disease
Hematology
Liver Disease
Rare Nephrology
Respiratory
Rare Disease
Cell & Gene Therapy
Capabilities
CATS
Consulting
Drug Depots
Global Regulatory
Health Equity & Inclusivity
Medical Writing
Pharmacovigilance & Drug Safety Services
Protocol Development & Feasibility
Quality Assurance
Trial Optimization
Clinical Monitoring & Site Management
Data Management
Patient Recruitment
Project Management
Rater Services
Tools & Technologies
Insights
Our Story
About Us
Meet the Team
Newsroom
Contact
Contact Us
Global Reach
Request Proposal
Home
/
Newsroom
/
Press Releases
Press Releases
Our latest company announcements.
Latest Press Releases
September 2, 2026
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
May 14, 2026
Worldwide Clinical Trials Strengthens Leadership Team – Demonstrating Global Focus and Deepening Therapeutic Expertise
April 23, 2026
Worldwide Clinical Trials and Medidata Announce Strategic Partnership to Embed Medidata AI Across the Full Trial Life...
February 16, 2026
Worldwide Clinical Trials Completes Acquisition of Catalyst Clinical Research
January 20, 2026
Worldwide Clinical Trials Enters Definitive Agreement to Acquire Catalyst Clinical Research
Learn more about
Worldwide Clinical Trials
Meet us at an event
Schedule a consultation
Request a proposal
Press Releases Archive
September 5, 2024
Alessandra Vignola Joins Worldwide Clinical Trials as President of Cardiovascular & Metabolic
July 23, 2024
Worldwide Clinical Trials Partners with PI-House and Polish Psychedelic Society for First Industry-Sponsored Psychedelic Studies in Poland
June 25, 2024
Worldwide Clinical Trials Recognized as Highest Rated Phase I Provider for Overall User Preference in 2024 Industry Standard Research Phase I Benchmarking Report
June 12, 2024
Worldwide Clinical Trials Ranked as Top CRO for Overall Performance In 2024 Industry Standard Research Phase II/III Benchmarking Report
May 1, 2024
Worldwide Clinical Trials Recognized with Coveted 2024 CRO Leadership Awards Based on Customer Feedback for 11th Consecutive Year
February 21, 2024
Worldwide Clinical Trials Expands Clinical Pharmacology Unit Pharmacy To Enhance Customer Experience; Adds Efficiencies and Decreases Timelines
February 15, 2024
Worldwide Clinical Trials Launches ‘Rare Moments’ Website, Giving Rare Disease Patients, Family Members, Researchers, and Supporters the Opportunity to Share Transformative Experiences and Build Community
February 8, 2024
Industry Survey: Pharma and Biotech Firms Increasingly Concerned About the Stability of Large CROs Amid Industry Consolidation
December 12, 2023
Worldwide Clinical Trials Completes Recapitalization with Kohlberg & Company
Previous
Next